Isis Pharmaceuticals' CEO, Dr. Stanley Crooke, Receives Prestigious SCRIP Lifetime Achievement Award
Dicerna Announces the Appointment of Theodore T. Ashburn, M.D., Ph.D. to Senior Vice President, Product Strategy and Operations, and Inducement Grant of Stock Options under NASDAQ Listing Rule 5635 (c)(4)
Alnylam Files Clinical Trial Application (CTA) for ALN-CC5, an RNAi Therapeutic Targeting Complement C5 in Development for the Treatment of Complement-Mediated Diseases
Research and Markets: EU5 Wound Closure Devices Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien and Baxter International
Research and Markets: Fabry Disease - Pipeline Review, H2 2014
The drugmaker faces less long-term volatility as the focus shifts to steady businesses.
Sanofi Receives FDA Approval of Priftin® (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection
Bertilimumab Chosen as a Top Autoimmune/Anti-Inflammatory Projects to Watch
A roundup of investment news.